PR featuring CBDT in case you missed it Today sucked but it's nice to see Empower featured in another PR. The article is quite long but here is what you need to hear: :)
Vaccination Passports Gain Traction Internationally; Canadian Companiess Pave Way for Implementation
The introduction of such a requirement would bring the rapid testing sector to the forefront and come with the need for rapid and efficient nationwide deployment – both of large-scale testing and vaccination ID systems. Two standout Canadian companies find themselves ready to tackle both issues: they are ScreenPro Ltd. and Empower Clinics.
Empower Clinics Inc. ( CSE: CBDT ) is a medical cannabis clinic owner and operator that shifted its attention to the pandemic. They’re known for developing medical marijuana products for the US and Canadian markets. The company runs health and wellness clinics in Canada and acquired the Kai Medical Laboratory in late 2020.
The acquisition introduced Empower to the coronavirus testing sector - as Kai Medical Laboratory can execute and process a RT-PCR Covid-19 test, an Anti-SARS-CoV-2 immunoassay, an antibody test for Covid-19 and a variety of other toxicologyy and hormone tests. Their focus is now on meeting the testing requirements of Canadian companies, institutions, and citizens.
Ahead of the curve
Empower’s recent direction turn has it focused on its covid-19 testing solutions – and the results speak for themselves. Just last week, the company secured contracts with two film and television productions. The deal will have CBDT process up to 5,000 tests, and net $750,000 over two months.
Empower jumped to the sector early in the pandemic, recording tests as early as March 2020. Recently disclosed Q1 reports show a 460% YoY growth in patient counts for the month , having served 5,717 in March 2020 vs. 26,317 in March 2021. They have announced they will now foray into U.S. Federal Government RFP bids.